Scientists uncover hidden layer of human genome with over 1,700 dark proteins

A new study has revealed a previously concealed layer of the human genome, with an international research team finding evidence that more than 1,700 so-called "dark" proteins are produced from regions of the genome not previously thought capable of this kind of biological activity.

From junk DNA to the dark genome

For much of scientific history, the vast majority of human DNA was dismissed as "junk" with no meaningful biological role. In recent years, however, that understanding has shifted — this previously ignored genetic landscape has been found to contain an extensive array of switches and controls acting on regular genes, a region now referred to as the "dark genome."

This latest study adds evidence that the dark genome does not merely modify other genes, but actively produces its own "dark proteome" — protein-like molecules that fall outside conventional definitions.

"We know that the current overview of recognised proteins doesn't capture the full picture," says paediatric oncologist Sebastiaan van Heesch from the Princess Máxima Center in the Netherlands.

"With this study, we show that thousands of overlooked genetic sequences contribute to the dark proteome by producing a new class of protein-like molecules, microproteins, that had been missed before now."

How the discovery was made

The team analysed 3.7 billion data points gathered from 95,520 separate experiments — a process requiring approximately 20,000 hours of computing time — ultimately identifying 1,785 microproteins. The researchers have coined the term "peptideins" to describe them, reflecting their ambiguous nature between peptides and fully fledged proteins.

"It's like the trailer to a movie. We see the outline of a game-changing view of human biology," says University of Michigan paediatric neuro-oncologist John Prensner.

A potential link to cancer treatment

One peptidein, produced from a gene previously considered noncoding called OLMALINC, is associated with cancer survival. When researchers deactivated it in laboratory tests, cancer cells struggled to grow — suggesting peptides may one day prove valuable in the development of new therapies.

"We're incredibly excited that the coming years will open new doors to help solve and treat human diseases such as cancer," says Prensner.

Wider implications

"The discovery of hundreds of peptideins gives visibility to a vast and previously overlooked layer of the genome," says geneticist Norbert Hübner from the Max Delbrück Center in Germany.

"Understanding their roles could transform how we study human disease, including cardiovascular disorders, and may reveal entirely new therapeutic opportunities."